We are live on ! Find out more
Freestone Grove Partners

Freestone Grove Partners Portfolio holdings

AUM $15.6B Turnover 60.27%
1-Year Est. Return 27.39%
This Fund
S&P 500
This Quarter Est. Return
+14.49%
1 Year Est. Return
+27.39%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$15.6B
AUM Growth
+$1.42B
Cap. Flow
+$81.1M
Cap. Flow %
0.52%
Top 10 Hldgs %
22.3%
Holding
1,397
New
435
Increased
253
Reduced
266
Closed
407
Avg Time Held Equity + Options
0.3 years
Top 10 Avg Time Held Equity + Options
0.2 years
Top 20 Avg Time Held Equity + Options
0.1 years
Avg Time Held Equity only
0.3 years
Top 10 Avg Time Held Equity only
0.2 years
Top 20 Avg Time Held Equity only
0.2 years

Sector Composition

Rank Sector Weight
1 Industrials 19.5%
2 Financials 16.81%
3 Miscellaneous 15.64%
4 Technology 13.57%
5 Healthcare 10.16%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
WEN icon
976
Wendy's
WEN
$1.24B
$8 ﹤0.01%
1
-56,745
-100% -$406K
2026 Q1
1 quarter
UPB icon
977
Upstream Bio Inc
UPB
$154M
$7 ﹤0.01%
1
– –
2026 Q1
1 quarter
ANGI icon
978
Angi Inc
ANGI
$261M
$6 ﹤0.01%
1
– –
2025 Q4
2 quarters
MYGN icon
979
Myriad Genetics
MYGN
$530M
$6 ﹤0.01%
+1
New +$5
2026 Q2
0 quarters
SOUN icon
980
SoundHound AI
SOUN
$2.09B
$6 ﹤0.01%
+1
New +$8
2026 Q2
0 quarters
WEAV icon
981
Weave Communications
WEAV
$595M
$6 ﹤0.01%
1
– –
2026 Q1
1 quarter
TMQ icon
982
Trilogy Metals
TMQ
$414M
$4 ﹤0.01%
+1
New +$4
2026 Q2
0 quarters
SLDP icon
983
Solid Power
SLDP
$461M
$3 ﹤0.01%
1
– –
2026 Q1
1 quarter
CCO icon
984
DELISTED
Clear Channel Outdoor Holdings
CCO
$2 ﹤0.01%
+1
New +$2
2026 Q2
0 quarters
CLVT icon
985
Clarivate
CLVT
$1.14B
$2 ﹤0.01%
1
– –
2026 Q1
1 quarter
CMPX icon
986
Compass Therapeutics
CMPX
$150M
$2 ﹤0.01%
+1
New +$3
2026 Q2
0 quarters
MVST icon
987
Microvast
MVST
$195M
$2 ﹤0.01%
2
– –
2026 Q1
1 quarter
RC icon
988
Ready Capital
RC
$195M
$2 ﹤0.01%
1
– –
2026 Q1
1 quarter
RR icon
989
Richtech Robotics
RR
$277M
$2 ﹤0.01%
1
– –
2026 Q1
1 quarter
ALIT icon
990
Alight
ALIT
$227M
– –
0
– –
2026 Q1
1 quarter
AAON icon
991
Aaon
AAON
$6.09B
– –
-291,896
Closed -$24.2M –
ABBV icon
992
AbbVie
ABBV
$511B
– –
-2
Closed -$435 –
ABG icon
993
Asbury Automotive
ABG
$3.09B
– –
-1,615
Closed -$316K –
ABUS icon
994
Arbutus Biopharma
ABUS
$858M
– –
-18,006
Closed -$81K –
ACA icon
995
Arcosa
ACA
$7.24B
– –
-1,756
Closed -$186K –
ACVA icon
996
DELISTED
ACV Auctions
ACVA
– –
-37,799
Closed -$160K –
ADBE icon
997
Adobe
ADBE
$100B
– –
-5,675
Closed -$1.38M –
ADEA icon
998
Adeia
ADEA
$2.35B
– –
-18,255
Closed -$439K –
ADP icon
999
Automatic Data Processing
ADP
$116B
– –
-141,784
Closed -$28.8M –
ADTN icon
1000
Adtran
ADTN
$536M
– –
-7,731
Closed -$97.3K –

Similar funds

Freestone Grove Partners's Q2 2026 Portfolio in Review

As of Q2 2026, Freestone Grove Partners held 1,397 positions worth $15.6B, up 10% from $14.2B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Freestone Grove Partners's Q2 2026 filing shows 435 new, 253 increased, 266 reduced and 407 closed positions. Its largest new stake was Abbott: 1,372,846 shares worth $125M. The largest sale was Datadog, an estimated $128M.

By sector, the portfolio is most concentrated in Industrials at 20% of assets, up from 12% a quarter earlier, followed by Financials and Miscellaneous.

  • Freestone Grove Partners's largest Q2 2026 buy was Abbott: 1,372,846 shares worth $125M.
  • Freestone Grove Partners added most to iShares Core S&P 500 ETF in Q2 2026, an estimated $311M increase.
  • Freestone Grove Partners's biggest Q2 2026 reduction was Elastic, cutting an estimated $110M.
  • Freestone Grove Partners fully exited Datadog in Q2 2026, selling an estimated $128M.
  • Freestone Grove Partners's ten largest holdings make up 22% of its $15.6B portfolio in Q2 2026.
  • Freestone Grove Partners opened 435 new positions and closed 407 in Q2 2026.
  • Freestone Grove Partners's portfolio value rose 10% quarter-over-quarter to $15.6B.

Based on Freestone Grove Partners's 13F filing for Q2 2026, filed 14 Aug 2026.